Cargando…
In Vivo Anti-Tumor Activity of Polypeptide HM-3 Modified by Different Polyethylene Glycols (PEG)
HM-3, designed by our laboratory, is a polypeptide composed of 18 amino acids. Pharmacodynamic studies in vivo and in vitro indicated that HM-3 could inhibit endothelial cell migration and angiogenesis, thereby inhibiting tumor growth. However, the half-life of HM-3 is short. In this study, we modif...
Autores principales: | Liu, Zhendong, Ren, Yinling, Pan, Li, Xu, Han-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127140/ https://www.ncbi.nlm.nih.gov/pubmed/21731464 http://dx.doi.org/10.3390/ijms12042650 |
Ejemplares similares
-
In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection
por: Gjetting, Torben, et al.
Publicado: (2010) -
The application of polyethylene glycol (PEG) to electron microscopy
Publicado: (1980) -
On the Behavior
of the Ethylene Glycol Components
of Polydisperse Polyethylene Glycol PEG200
por: Hoffmann, Markus M., et al.
Publicado: (2023) -
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
por: Kozma, Gergely Tibor, et al.
Publicado: (2023) -
Safety Evaluation of Polyethylene Glycol (PEG) Compounds for Cosmetic Use
por: Jang, Hyun-Jun, et al.
Publicado: (2015)